Rationale and preclinical development of LEAF-1401 and LEAF-1701: A novel class of potent next generation antifolates

MLA

Victor Moyo, et al. “Rationale and Preclinical Development of LEAF-1401 and LEAF-1701: A Novel Class of Potent next Generation Antifolates.” Journal of Clinical Oncology, vol. 37, May 2019, p. e14515. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d5d3d71439fb1b9d686aed92f13690b8&authtype=sso&custid=ns315887.

APA

Victor Moyo, Zhenghong Xu, Navreet Dhindsa, Nishant Gandhi, Clet Niyikiza, Bolin Geng, & Kaniz Khalifa. (2019). Rationale and preclinical development of LEAF-1401 and LEAF-1701: A novel class of potent next generation antifolates. Journal of Clinical Oncology, 37, e14515.

Chicago

Victor Moyo, Zhenghong Xu, Navreet Dhindsa, Nishant Gandhi, Clet Niyikiza, Bolin Geng, and Kaniz Khalifa. 2019. “Rationale and Preclinical Development of LEAF-1401 and LEAF-1701: A Novel Class of Potent next Generation Antifolates.” Journal of Clinical Oncology 37 (May): e14515. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........d5d3d71439fb1b9d686aed92f13690b8&authtype=sso&custid=ns315887.